Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update.

MLA

McFarthing, Kevin, et al. “Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update.” Journal of Parkinson’s Disease, vol. 13, no. 4, 2023, pp. 427–39. EBSCOhost, https://doi.org/10.3233/JPD-239901.

APA

McFarthing, K., Buff, S., Rafaloff, G., Fiske, B., Mursaleen, L., Fuest, R., Wyse, R. K., & Stott, S. R. W. (2023). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update. Journal of Parkinson’s Disease, 13(4), 427–439. https://doi.org/10.3233/JPD-239901

Chicago

McFarthing, Kevin, Susan Buff, Gary Rafaloff, Brian Fiske, Leah Mursaleen, Rosie Fuest, Richard K Wyse, and Simon R W Stott. 2023. “Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update.” Journal of Parkinson’s Disease 13 (4): 427–39. doi:10.3233/JPD-239901.